SLNSW-Neoadjuvant atezolizumab in combination with sequ...-TN_cdi_proquest_journals_2449447108

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Full title: Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Author/creator: Mittendorf, Elizabeth A, Zhang, Hong, Barrios, Carlos H, Saji, Shigehira, Jung, Kyung Hae, Hegg, Roberto, Koehler, Andreas, Sohn, Joohyuk, Iwata, Hiroji, Telli, Melinda L, Ferrario, Cristiano, Punie, Kevin, Penault-Llorca, Frédérique, Patel, Shilpen, Duc, Anh Nguyen, Liste-Hermoso, Mario, Maiya, Vidya, Molinero, Luciana, Chui, Stephen Y, Harbeck, Nadia.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2449447108

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2449447108

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

    Record identifier

    TN_cdi_proquest_journals_2449447108

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2449447108

    Share

    Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2449447108

    Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

    Full title

    Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

    Author / Creator

    Mittendorf, Elizabeth A ; Zhang, Hong ; Barrios, Carlos H ; Saji, Shigehira ; Jung, Kyung Hae ; Hegg, Roberto ; Koehler, Andreas ; Sohn, Joohyuk ; Iwata, Hiroji ; Telli, Melinda L ; Ferrario, Cristiano ; Punie, Kevin ; Penault-Llorca, Frédérique ; Patel, Shilpen ; Duc, Anh Nguyen ; Liste-Hermoso, Mario ; Maiya, Vidya ; Molinero, Luciana ; Chui, Stephen Y ; Harbeck, Nadia

    Publisher

    England: Elsevier Ltd

    Journal title

    The Lancet (British edition), 2020, Vol.396 (10257), p.1090-1100

    Record Identifier

    TN_cdi_proquest_journals_2449447108

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Albumins Albumins - administration & dosage Anthracycline Anthracyclines Antibodies, Monoclonal, Humanized Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antigens Antineoplastic Agents Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Apoptosis Breast cancer Cancer Cancer therapies Care and treatment Cell death Chemotherapy Clinical trials Cyclophosphamide Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Double-Blind Method Doxorubicin Doxorubicin - administration & dosage Doxorubicin - adverse effects Female Humans Immune system Immunotherapy Information centers Intravenous administration Life Sciences Ligands Medical prognosis Metastasis Middle Aged Monoclonal antibodies Neoadjuvant Therapy Oncology Paclitaxel Paclitaxel - administration & dosage Patients PD-L1 protein Population Population studies Product development Safety Surgery Targeted cancer therapy Taxanes Traffic accidents Triple Negative Breast Neoplasms Triple Negative Breast Neoplasms - drug therapy Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2449447108

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2449447108

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    About resource >

    View in old catalogue

    Connecting people and collections